William R. Ewing
85Patents
11h-index
129Co-inventors
81Inventor score
Filing activity: Aug 24, 1990 → Feb 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5441944A | Substituted cyclodextrin sulfates and their uses as growth modulating agents | Human Necessities | 46 | Expired |
| US5612353A | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds | Chemistry; Metallurgy | 33 | Expired |
| US7858639B2 | Bicyclic heterocycles as cannabinoid-1 receptor modulators | Chemistry; Metallurgy | 25 | Active |
| US6281227A | Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | Chemistry; Metallurgy | 24 | Expired |
| US7238671B2 | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | Human Necessities | 17 | Expired |
| US7238670B2 | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | Human Necessities | 17 | Expired |
| US5162336A | Tetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonists | Chemistry; Metallurgy | 16 | Expired |
| US8557841B2 | Heterocyclic aromatic compounds useful as growth hormone secretagogues | Chemistry; Metallurgy | 15 | Active |
| US7417028B2 | Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions | Human Necessities | 14 | Expired |
| US6034093A | Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds | Chemistry; Metallurgy | 12 | Expired |
| US9221818B2 | Macrocycles as factor XIa inhibitors | Chemistry; Metallurgy | 12 | Active |
| US6376472B1 | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties | Chemistry; Metallurgy | 11 | Expired |
| US7157461B2 | Substituted dihydropyrimidine inhibitors of calcium channel function | Chemistry; Metallurgy | 9 | Expired |
| US6559313B2 | Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties | Chemistry; Metallurgy | 9 | Expired |
| US5340801A | Compounds having cholecystokinin and gastrin antagonistic properties | Human Necessities | 8 | Expired |
| US5731315A | Substituted sulfonic acid n-(aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds | Chemistry; Metallurgy | 8 | Expired |
| US7884113B2 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | Chemistry; Metallurgy | 7 | Active |
| US8119808B2 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | Chemistry; Metallurgy | 6 | Active |
| US7517991B2 | N-sulfonylpiperidine cannabinoid receptor 1 antagonists | Chemistry; Metallurgy | 6 | Active |
| US7166596B2 | Heterocyclic aromatic compounds useful as growth hormone secretagogues | Chemistry; Metallurgy | 6 | Expired |
| US9611274B2 | Macrocycles as factor XIa inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10208068B2 | Macrocycles as factor XIa inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7037910B2 | Azabicyclic heterocycles as cannabinoid receptor modulators | Human Necessities | 5 | Expired |
| US9902742B2 | Macrocycles as factor XIa inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7378418B2 | Azabicyclic heterocycles as cannabinoid receptor modulators | Human Necessities | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.